News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Jin Zhang

Articles by Jin Zhang

21 Distant Disease-Free Survival Across Key Subgroups From the Phase 3 NATALEE Trial of Ribociclib Plus a Nonsteroidal Aromatase Inhibitor in Patients With HR+/HER2− Early Breast Cancer

BySara A. Hurvitz, MD,Michal Jarzab,Montserrat Munoz Mateu,Erin Cobain,Jin Zhang,Arielle Medford,Alistair Ring,Priyanka Sharma, MD,Christian Schem, MD,Ionut Temciuc,Zheng Li,Juan Pablo Zarate,Denise A. Yardley, MD

June 26th 2025

Latest Updated Articles

21 Distant Disease-Free Survival Across Key Subgroups From the Phase 3 NATALEE Trial of Ribociclib Plus a Nonsteroidal Aromatase Inhibitor in Patients With HR+/HER2− Early Breast Cancer
June 26th 2025

Trending on CancerNetwork

FDA Issues Second CRL for RP1/Nivolumab in Advanced Melanoma

AI-Driven Risk Assessment is Transforming Breast Cancer Screening

FDA Accepts NDA for Imaging Agent TLX101-Px in Brain Cancer

FDA Lifts Partial Clinical Hold on Lorigerlimab for Gynecologic Cancer

FDA Grants Orphan Drug Designation to Tovecimig for Biliary Tract Cancer